J.-P. Sauvage, J. F. Stoddart et al.
a white solid (150 mg, 0.19 mmol) in a 54% yield. 1H NMR (CD3CN,
500 MHz, 293 K): d=8.86 (m, 4H), 8.75 (d, 3J=6.7 Hz, 4H), 8.32 (m,
4H), 7.79 (m, 6H), 7.57 (d, 3J=8.0 Hz, 1H), 6.09 (s, 2H), 5.85 (s, 2H),
6.9 Hz, 2H), 7.82 (m, 4H), 7.68 (d, 3J=7.9 Hz, 1H), 7.51 (d, 3J=1.4 Hz,
1H), 7.35 (dd, 3J=7.9 Hz, 4J=1.4 Hz, 1H), 5.78 (s, 2H), 5.67 ppm (s,
2H); 13C NMR (CD3CN, 125 MHz, 293 K): d=154.2, 153.9, 150.2, 150.1,
144.9, 144.7, 141.6, 141.4, 140.7, 136.2, 135.2, 132.7, 126.0, 125.6, 124.3,
121.9, 121.8, 120.1, 62.7, 59.6 ppm; HR-ESI-MS: m/z calcd for [MÀPF6]+:
602.1651; found: 602.1660.
4.9 (d, J=2.5 Hz, 2H), 2.85 ppm (t, J=2.5 Hz, 1H); 13C NMR (CD3CN,
125 MHz, 293 K): d=165.72, 155.86, 155.62, 152.14, 152.11, 150.43,
147.12, 146.15, 142.03, 141.97, 136.27, 135.46, 135.38, 134.41, 133.73,
131.02, 127.33, 126.81, 123.03, 122.84, 78.15, 77.16, 63.75, 62.85,
54.31 ppm; HR-ESI-MS: m/z calcd for [MÀPF6]+: 643.1703; found:
643.1694.
4
4
General procedure for cyclophane formation: Precursor salt (0.14 mmol),
dibromide
(0.14 mmol),
and
the
template—1,5-bisACHTUNGTRENNUNG[ethoxy-
AHCTUNGTREG(NNUN ethoxy)]dioxynaphthalene (DNP-DEG) (238 mg, 0.41 mmol)—were
Synthesis of compound 10: Dibromide 9[28] (2.357 g, 6.03 mmol), proparg-
yl bromide (0.676 g, 12.06 mmol), a catalytic amount of pyridinium p-tol-
uenesulfonate, and a catalytic amount of 4-dimethylaminopyridine were
combined in CH2Cl2 (150 mL) at RT. Dicyclohexyl carbodiimide (2.48 g,
12.06 mmol) was added to the CH2Cl2 solution and the reaction was left
under stirring for 12 h. The crude product was purified by column chro-
matography (SiO2, hexanes/EtOAc) to afford the pure dibromide 10
(2.14 g, 4.99 mmol) in an 82% yield. 1H NMR (CD3CN, 500 MHz,
293 K): d=7.79 (s, 2H), 4.98 (s, 4H), 4.78 (d, 4J=2.6 Hz, 2H), 4.45 (s,
2H), 2.84 ppm (t, 4J=2.6 Hz, 1H); 13C NMR (CD3CN, 125 MHz, 293 K):
d=167.9, 167.5, 138.5, 137.7, 129.5, 78.1, 76.8, 54.0, 39.5, 27.1 ppm; HR-
ESI-MS: m/z calcd for C15H11O4NBr2 [M]+: 426.9055; found: 426.9042.
combined in dry DMF (250 mL) and the solution was stirred at 258C for
5 days before the solvent was removed in vacuo. The crude reaction mix-
ture was stirred in a saturated aqueous solution of NH4Cl until the resi-
due dissolved, after which it was diluted with H2O (ca. 400 mL). Liquid–
liquid extraction using CHCl3 (2 L) was employed to remove the DNP-
DEG template (2 days). The remaining crude product was precipitated
by the addition of NH4PF6 and RP-HPLC was used to attempt to purify
the final product. Precursors 6·2PF6, 8·2PF6, and 11·2PF6 were utilized in
attempts to form tetracationic cyclophanes that failed for the most part.
Synthesis of compound 2·4PF6: Precursor 14·2PF6 (120 mg, 0.15 mmol),
dibromide 13 (50 mg, 0.15 mmol), and the template DNP-DEG (250 mg,
0.75 mmol) were combined in dry DMF (35 mL), and the solution was
stirred at 258C for 5 days before the solvent was removed in vacuo. The
crude reaction mixture was stirred in a saturated aqueous solution of
NH4Cl until the residue dissolved, after which it was diluted with H2O
(ca. 400 mL). Liquid–liquid extraction using CHCl3 (2 L) was employed
to remove the DNP-DEG template (2 days). The remaining crude prod-
uct was precipitated by the addition of NH4PF6 and purified by column
chromatography (SiO2, 2m NH4Cl/MeOH/MeNO2 12:7:1) to yield the
isomeric mixture of bisazides 2·4PF6 as an off-white solid (45.5 mg,
Synthesis of compound 11·2PF6: Dibromide 9 (305 mg, 0.35 mmol) and
4,4’-bipyridine (325 mg, 2.1 mmol) were combined in MeCN (50 mL) and
heated under reflux for 12 h. The crude reaction mixture was filtered, the
residue dissolved in H2O (200 mL), and the crude product precipitated
by the addition of NH4PF6. Column chromatography (SiO2, 2m NH4Cl/
MeOH/MeNO2 12:7:1) was employed to afford 11·2PF6 as a white solid
(190 mg, 0.22 mmol) in
a
75% yield. 1H NMR (CD3CN, 500 MHz,
293 K): d=8.86 (m, 8H), 8.33 (d, 2J=6.4 Hz, 4H), 7.88 (s, 2H), 7.79 (d,
2J=6.4 Hz, 4H), 6.17 (s, 4H), 4.75 (d, 4J=2.4 Hz, 2H), 4.45 (s, 2H),
2.85 ppm (t, 4J=2.4 Hz, 1H); 13C NMR (CD3CN, 125 MHz, 293 K): d=
167.7, 167.5, 156.0, 152.0, 146.6, 141.9, 137.8, 133.2, 131.6, 127.0, 122.8,
78.0, 77.0, 59.8, 54.1, 39.7 ppm; HR-ESI-MS: m/z calcd for [MÀPF6]+:
725.1705; found: 726.1720.
1
0.04 mmol) in a 27% yield. H NMR (CD3CN, 500 MHz, 293 K): d=8.90
(m, 8H) 8.17 (m, 8H), 7.65 (d, 3J=7.81 Hz, 2H), 7.42 (dd, 3J=7.81 Hz,
4J=1.55 Hz, 1H), 7.41 (dd, 3J=7.81 Hz, 4J=1.55 Hz, 1H), 7.32 (d, 3J=
1.55 Hz, 2H), 5.73 (s, 4H), 5.68 ppm (s, 4H); 13C NMR (CD3CN,
125 MHz, 293 K): d=150.57, 150.46, 146.74, 146.68, 146.20, 146.15,
141.61, 141.57, 138.70, 138.62, 133.60, 133.53, 128.33, 128.27, 127.75,
127.69, 127.10, 127.04, 121.04, 120.98, 65.09, 61.25, 61.22 ppm; ESI-MS:
m/z calcd for [MÀPF6]+: 1037.1580; found: 1037.1579.
Synthesis of compound 12: Compound 12 was prepared using a modified
procedure developed by Molander et al.[31] Commercially available 2-
bromo-p-xylene (30.0 g, 162 mmol), NaN3 (10.5 g, 162 mmol), CuBr
(2.4 g, 16.7 mmol), Cs2CO3 (26.4 g, 81 mmol), and N,N’-dimethylethylene-
diamine (2.85 g, 32.3 mmol) were combined in dry DMF (500 mL) and
the solution was heated to 908C with stirring. After 12 h, H2O (500 mL)
was added and the product was extracted with EtOAc (3ꢂ400 mL). Sol-
vent was removed in vacuo and the product was purified by column chro-
matography (SiO2, hexanes). The fractions containing the product were
combined and the solvent was removed in vacuo to yield the azide 12 as
Synthesis of compound 15: NaH (60% in mineral oil, 40 mg, 1 mmol)
was added to a solution of DNP-HEG-OH[29] (185 mg, 0.269 mmol) in
dry DMF (20 mL) and stirred for 15 min. Propargyl bromide (80% w/w
in PhMe, 0.25 mL, 2.3 mmol) was added slowly, and the mixture stirred
for 16 h. MeOH (5 mL) was added carefully to quench remaining NaH,
the solvents were removed in vacuo to yield a brown oil, which was puri-
fied by column chromatography (SiO2, Me2CO/CH2Cl2 5:95) to yield the
product 15 as a light brown oil (137 mg, 0.179 mmol) in a 67% yield.
1H NMR (CDCl3, 500 MHz, 293 K): d=7.85 (d, 3J=8.4 Hz, 2H), 7.34 (t,
3J=7.8 Hz, 2H), 6.84 (d, 3J=7.8 Hz, 2H), 4.29 (t, 3J=5.0 Hz, 4H), 4.19
a
yellow oil (20.5 g, 139 mmol) in a
86% yield. 1H NMR (CDCl3,
500 MHz, 293 K): d=7.04 (d, 3J=7.7 Hz, 1H), 6.93 (s, 1H), 6.85 (d, 3J=
7.7 Hz, 1H), 2.34 (s, 3H), 2.17 ppm (s, 3H). The 1H NMR spectrum of
the product matches that previously reported.[15a]
3
3
(d, J=2.4 Hz, 4H), 3.99 (t, J=5.2 Hz, 4H), 3.80 (m, 4H), 3.62–3.71 (m,
18H), 2.43 ppm (t, 3J=2.3 Hz, 2H); 13C NMR (CDCl3, 125 MHz, 293 K):
d=154.4, 126.9, 125.2, 114.7, 105.7, 79.8, 74.7, 71.1, 70.8, 70.7, 70.7, 70.7,
70.7, 70.7, 70.5, 70.0, 69.2, 68.0, 58.5 ppm; ESI-MS: m/z calcd for [M+
Na]+: 782.4364; found: 782.4340.
Synthesis of compound 13: Compound 12 (294 mg, 2.0 mmol), N-bromo-
succinimide (764 mg, 4.3 mmol), and AIBN (50 mg, 0.37 mmol) were
combined in dry CCl4 (50 mL) and heated under reflux for 12 h. The mix-
ture was cooled and filtered to remove the insoluble solid. The solvent
was then evaporated under reduced pressure and purified by silica gel
column chromatography (SiO2, CH2Cl2/hexanes 1:6) to give 13[15a] as
a white solid (310 mg, 0.9 mmol) in a 47% yield. 1H NMR (500 MHz,
CDCl3, 298 K): d=7.35 (d, 3J=7.8 Hz, 1H), 7.18 (d, 3J=1.4 Hz, 1H),
7.14 (dd, 3J=7.8 Hz, 4J=1.4 Hz, 1H), 4.47 (s, 2H), 4.46 ppm (s, 2H);
13C NMR (125 MHz, CDCl3, 298 K): d=138.9, 138.0, 130.7, 127.9, 124.6,
117.9, 30.9, 26.7 ppm; HR-ESI-MS: m/z calcd for [M]+: 302.9007; found:
302.9001.
Synthesis of figure-of-eight 1·4PF6: The bisazides 2·4PF6 (68.3 mg,
0.06 mmol) and guest 15 (39.7 mg, 0.06 mmol) were degassed in DMF
(25 mL) with argon before addition of CuI (1.1 mg, 0.006 mmol) and the
solution was stirred for 2 days. Solvent was removed in vacuo and the
crude product was precipitated from H2O by the addition of NH4PF6
before being purified further using reverse phase high-performance
liquid chromatography (RP-HPLC) (MeCN/H2O 0–40% in 55 min) to
yield a pink solid 1·4PF6 as a mixture of constitutional isomers of
(13.0 mg, 0.006 mmol) in a 12% yield. 1H NMR (CD3CN, 500 MHz,
293 K): d=9.36 (d, 3J=6.8 Hz, 2H), 9.31 (d, 3J=6.8 Hz, 2H), 8.97 (d,
3J=6.8 Hz, 2H), 8.92 (d, 3J=6.8 Hz, 2H), 8.70 (d, 3J=6.8 Hz, 2H), 8.67
(d, 3J=6.8 Hz, 2H), 8.55 (s, 2H), 8.54 (s, 2H), 8.50 (d, 3J=8.5 Hz, 4H),
8.30 (dd, 3J=8.5 Hz, 4J=2.5 Hz 4H), 8.14 (d, 4J=2.5 Hz, 7.82 (d, 3J=
6.8 Hz, 2H), 4H), 7.80 (d, 3J=6.8 Hz, 2H), 7.45 (dd, 4J=2.4 Hz, 3J=
6.8 Hz, 2H), 7.40 (dd, 4J=2.4 Hz, 3J=6.8 Hz, 2H), 7.38 (dd, 4J=2.4 Hz,
3J=6.8 Hz, 2H), 7.35 (dd, 4J=2.4 Hz, 3J=6.8 Hz, 2H), 7.31 (dd, 4J=
Synthesis of compound 14·2PF6: Dibromide 13[15a] (300 mg, 0.9 mmol)
and 4,4’-bipyridine (922 mg, 5.9 mmol) were combined in MeCN (50 mL)
and heated under reflux for 12 h. The crude reaction mixture was fil-
tered, the residue dissolved in H2O (200 mL), and the crude product pre-
cipitated by the addition of NH4PF6. Column chromatography (SiO2, 2m
NH4Cl/MeOH/MeNO2 12:7:1) was employed to obtain 14·2PF6 as
a white solid (605 mg, 0.81 mmol) in a 94% yield. 1H NMR (CD3CN,
3
3
500 MHz, 293 K): d=8.86 (m, 8H), 8.33 (d, J=6.9 Hz, 2H), 8.29 (d, J=
&
10
&
ꢁ 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 0000, 00, 0 – 0
ÝÝ
These are not the final page numbers!